Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Invested Capital (2022 - 2023)

Historic Return on Invested Capital for Cullinan Therapeutics (CGEM) over the last 2 years, with Q3 2023 value amounting to 0.36%.

  • Cullinan Therapeutics' Return on Invested Capital fell 5300.0% to 0.36% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.36%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 0.22% for FY2022, which is N/A changed from last year.
  • Per Cullinan Therapeutics' latest filing, its Return on Invested Capital stood at 0.36% for Q3 2023, which was down 5300.0% from 0.32% recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Return on Invested Capital high stood at 0.21% for Q2 2022, and its period low was 0.36% during Q3 2023.